These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 16495068

  • 1. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.
    Opitz I, Kestenholz P, Lardinois D, Müller M, Rousson V, Schneiter D, Stahel R, Weder W.
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):579-84. PubMed ID: 16495068
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W, Kestenholz P, Taverna C, Bodis S, Lardinois D, Jerman M, Stahel RA.
    J Clin Oncol; 2004 Sep 01; 22(17):3451-7. PubMed ID: 15337794
    [Abstract] [Full Text] [Related]

  • 3. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD, Boyer M, Tin MM, Wong D, Kennedy C, McLean J, Bannon PG, McCaughan BC.
    J Thorac Cardiovasc Surg; 2009 Sep 01; 138(3):619-24. PubMed ID: 19698846
    [Abstract] [Full Text] [Related]

  • 4. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
    de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, Roberts H, Tsao MS, Leighl N, Keshavjee S, Johnston MR.
    J Clin Oncol; 2009 Mar 20; 27(9):1413-8. PubMed ID: 19224855
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A, Früh M, Cathomas R, Nackaerts K, Peters S, Mamot C, Zippelius A, Mordasini C, Caspar CB, Eckhardt K, Schmid RA, Aebersold DM, Gautschi O, Nagel W, Töpfer M, Krayenbuehl J, Ribi K, Ciernik IF, Weder W.
    Lancet Oncol; 2015 Dec 20; 16(16):1651-8. PubMed ID: 26538423
    [Abstract] [Full Text] [Related]

  • 6. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
    Frischknecht L, Meerang M, Soltermann A, Stahel R, Moch H, Seifert B, Weder W, Opitz I.
    J Thorac Cardiovasc Surg; 2015 Jun 20; 149(6):1539-46.e1. PubMed ID: 25840756
    [Abstract] [Full Text] [Related]

  • 7. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma.
    Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O'Byrne KJ, Waller DA.
    Ann Thorac Surg; 2004 Jul 20; 78(1):245-52. PubMed ID: 15223437
    [Abstract] [Full Text] [Related]

  • 8. A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma.
    Yamanaka T, Tanaka F, Hasegawa S, Okada M, Soejima T, Kamikonya N, Fukuoka K, Nakano T.
    Jpn J Clin Oncol; 2009 Mar 20; 39(3):186-8. PubMed ID: 19131427
    [Abstract] [Full Text] [Related]

  • 9. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
    Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M, Obasaju CK, Vogelzang NJ.
    J Clin Oncol; 2009 Jun 20; 27(18):3007-13. PubMed ID: 19364962
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: the Memorial Sloan-Kettering experience.
    Flores RM.
    Lung Cancer; 2005 Jul 20; 49 Suppl 1():S71-4. PubMed ID: 15950805
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe?
    Utkan G, Yalçin B, Büyükçelik A, Yalçin S.
    J Clin Oncol; 2005 Jan 20; 23(3):655; author reply 655. PubMed ID: 15659523
    [No Abstract] [Full Text] [Related]

  • 12. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
    Pasello G, Nicotra S, Marulli G, Rea F, Bonanno L, Carli P, Magro C, Jirillo A, Favaretto A.
    Lung Cancer; 2011 Sep 20; 73(3):351-5. PubMed ID: 21296448
    [Abstract] [Full Text] [Related]

  • 13. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
    Hasegawa S, Okada M, Tanaka F, Yamanaka T, Soejima T, Kamikonya N, Tsujimura T, Fukuoka K, Yokoi K, Nakano T.
    Int J Clin Oncol; 2016 Jun 20; 21(3):523-30. PubMed ID: 26577445
    [Abstract] [Full Text] [Related]

  • 14. PI3K/mTOR signaling in mesothelioma patients treated with induction chemotherapy followed by extrapleural pneumonectomy.
    Bitanihirwe BK, Meerang M, Friess M, Soltermann A, Frischknecht L, Thies S, Felley-Bosco E, Tsao MS, Allo G, de Perrot M, Seifert B, Moch H, Stahel R, Weder W, Opitz I.
    J Thorac Oncol; 2014 Feb 20; 9(2):239-47. PubMed ID: 24419422
    [Abstract] [Full Text] [Related]

  • 15. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P, Sylvestre A, Lisbona A, Zefkili S, Bonnette P, Le Pimpec Barthes F, Michaud JL, Perigaud C, Mahé MA.
    Rev Mal Respir; 2011 May 20; 28(5):609-17. PubMed ID: 21645831
    [Abstract] [Full Text] [Related]

  • 16. [Malignant mesothelioma of the pleura: place of surgery].
    Giudicelli R, Regnard JF, Astoul P, Ruffie P.
    Rev Mal Respir; 2006 Sep 20; 23(4 Pt 2):10S106-10S109. PubMed ID: 17127980
    [No Abstract] [Full Text] [Related]

  • 17. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
    Thieke C, Nicolay NH, Sterzing F, Hoffmann H, Roeder F, Safi S, Debus J, Huber PE.
    Radiat Oncol; 2015 Dec 30; 10():267. PubMed ID: 26715491
    [Abstract] [Full Text] [Related]

  • 18. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
    Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, Lardinois D, Betticher D, Schmid R, Stupp R, Ris HB, Jermann M, Mingrone W, Roth AD, Spiliopoulos A, Swiss Group for Clinical Cancer Research.
    Ann Oncol; 2007 Jul 30; 18(7):1196-202. PubMed ID: 17429100
    [Abstract] [Full Text] [Related]

  • 19. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations.
    Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA.
    Eur J Cardiothorac Surg; 2005 Mar 30; 27(3):373-8. PubMed ID: 15740941
    [Abstract] [Full Text] [Related]

  • 20. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W, Kirschbaum A, Passlick B.
    Zentralbl Chir; 2008 Jun 30; 133(3):231-7. PubMed ID: 18563687
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.